- McCullough PA
- Kelly RJ
- Ruocco G
- Lerma E
- Tumlin J
- Wheelan KR
- Katz N
- Lepor NE
- Vijay K
- Carter H
- Singh B
- McCullough SP
- Bhambi BK
- Palazzuoli A
- De Ferrari GM
- Milligan GP
- Safder T
- Tecson KM
- Wang DD
- McKinnon JE
- O'Neill WW
- Zervos M
- Risch HA.
- Prodromos C
- Rumschlag T.
- McCullough PA
- Alexander PE
- Armstrong R
- Arvinte C
- Bain AF
- Bartlett RP
- Berkowitz RL
- Berry AC
- Borody TJ
- Brewer JH
- Brufsky AM
- Clarke T
- Derwand R
- Eck A
- Eck J
- Eisner RA
- Fareed GC
- Farella A
- Fonseca SNS
- Geyer Jr, CE
- Gonnering RS
- Graves KE
- Gross KBV
- Hazan S
- Held KS
- Hight HT
- Immanuel S
- Jacobs MM
- Ladapo JA
- Lee LH
- Littell J
- Lozano I
- Mangat HS
- Marble B
- McKinnon JE
- Merritt LD
- Orient JM
- Oskoui R
- Pompan DC
- Procter BC
- Prodromos C
- Rajter JC
- Rajter JJ
- Ram CVS
- Rios SS
- Risch HA
- Robb MJA
- Rutherford M
- Scholz M
- Singleton MM
- Tumlin JA
- Tyson BM
- Urso RG
- Victory K
- Vliet EL
- Wax CM
- Wolkoff AG
- Wooll V
- Zelenko V.
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19. Tardif JC, Bouabdallaoui N, L'Allier PL, Gaudet D, Shah B, Pillinger MH, Lopez-Sendon J, da Luz P, Verret L, Audet S, Dupuis J, Denault J, Pelletier M, Tessier PA, Samson S, Fortin D, Tardif JD, Busseuil D, Goulet E, Lacoste C, Dubois A, Joshi AY, Waters DD, Hsue P, Lepor NE, Lesage F, Sainturet N, Roy-Clavel E, Bassevitch, Orfanos A, Grégoire JC, Busque L, Lavallée C, Hétu PO, Paquette JS, Levesque S, Cossette M, Nozza A, Chabot-Blanchet M, Dubé MP, Guertin MC, Boivin G, for the COLCORONA Investigators medRxiv 2021.01.26.21250494; doi: https://doi.org/10.1101/2021.01.26.21250494
Ramakrishnan S, Nicolau DV Jr., Langford B, Mahdi B, Jeffers H, Mwasuku C, Krassowska K, Fox R, Binnian I, Glover V, Bright S, Butler C, Cane JL, Halner A, Matthews PC, Donnelly LE, Simpson JL, Baker JR, Fadai NT, Peterson S, Bengtsson T, Barnes PJ, Russell REK, Bafadhel M. Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial. medRxiv 2021.02.04.21251134; doi: https://doi.org/10.1101/2021.02.04.21251134
- Derwand R
- Scholz M
- Zelenko V.
- Procter BC
- Ross C
- Pickard V
- Smith E
- Hanson C
- McCullough PA.
- Procter BC
- Ross C
- Pickard V
- Smith E
- Hanson C
- McCullough PA.
References
- Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.Am J Med. 2021 Jan; 134 (Epub 2020 Aug 7. PMID:32771461PMCID: PMC7410805): 16-22https://doi.org/10.1016/j.amjmed.2020.07.003
- Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review.New Microbes New Infect. 2020 Nov; 38 (Epub 2020 Oct 5. PMID:33042552PMCID: PMC7534595)100776https://doi.org/10.1016/j.nmni.2020.100776
Ladapo J, McKinnon JE, McCullough PA, Risch H. Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis doi: https://doi.org/10.1101/2020.09.30.20204693
- Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).Rev Cardiovasc Med. 2020 Dec 30; 21 (PMID:33387997): 517-530https://doi.org/10.31083/j.rcm.2020.04.264
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19. Tardif JC, Bouabdallaoui N, L'Allier PL, Gaudet D, Shah B, Pillinger MH, Lopez-Sendon J, da Luz P, Verret L, Audet S, Dupuis J, Denault J, Pelletier M, Tessier PA, Samson S, Fortin D, Tardif JD, Busseuil D, Goulet E, Lacoste C, Dubois A, Joshi AY, Waters DD, Hsue P, Lepor NE, Lesage F, Sainturet N, Roy-Clavel E, Bassevitch, Orfanos A, Grégoire JC, Busque L, Lavallée C, Hétu PO, Paquette JS, Levesque S, Cossette M, Nozza A, Chabot-Blanchet M, Dubé MP, Guertin MC, Boivin G, for the COLCORONA Investigators medRxiv 2021.01.26.21250494; doi: https://doi.org/10.1101/2021.01.26.21250494
Ramakrishnan S, Nicolau DV Jr., Langford B, Mahdi B, Jeffers H, Mwasuku C, Krassowska K, Fox R, Binnian I, Glover V, Bright S, Butler C, Cane JL, Halner A, Matthews PC, Donnelly LE, Simpson JL, Baker JR, Fadai NT, Peterson S, Bengtsson T, Barnes PJ, Russell REK, Bafadhel M. Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial. medRxiv 2021.02.04.21251134; doi: https://doi.org/10.1101/2021.02.04.21251134
- COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study.Int J Antimicrob Agents. 2020 Dec; 56 (Epub 2020 Oct 26. PMID:33122096PMCID: PMC7587171)106214https://doi.org/10.1016/j.ijantimicag.2020.106214
- Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection.Rev Cardiovasc Med. 2020 Dec 30; 21 (PMID:33388006): 611-614https://doi.org/10.31083/j.rcm.2020.04.260
- Early Ambulatory Multidrug Therapy Reduces Hospitalization and Death in High-Risk Patients with SARS-CoV-2 (COVID-19).Authorea. January 07, 2021; https://doi.org/10.22541/au.161000355.54720791/v1
Article info
Footnotes
Funding: none related
Conflict of Interest: Nothing to disclose
Author had access to the data and wrote the manuscript